Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12

Drug Delivery
Najla AltwaijryChristine Dufès

Abstract

The possibility of using gene therapy for the treatment of prostate cancer is limited by the lack of intravenously administered delivery systems able to safely and selectively deliver therapeutic genes to tumors. Given that lactoferrin (Lf) receptors are overexpressed on prostate cancer cells, we hypothesized that the conjugation of Lf to generation 3-diaminobutyric polypropylenimine dendrimer would improve its transfection and therapeutic efficacy in prostate cancer cells. In this study, we demonstrated that the intravenous administration of Lf-bearing DAB dendriplexes encoding TNFα resulted in the complete suppression of 70% of PC-3 and 50% of DU145 tumors over one month. Treatment with DAB-Lf dendriplex encoding TRAIL led to tumor suppression of 40% of PC-3 tumors and 20% of DU145 tumors. The treatment was well tolerated by the animals. Lf-bearing generation 3-polypropylenimine dendrimer is therefore a highly promising delivery system for non-viral gene therapy of prostate cancer.

References

Jan 1, 1984·Virchows Archiv. A, Pathological Anatomy and Histopathology·G Barresi, G Tuccari
Sep 24, 1999·Advances in Genetics·R I MahatoA Rolland
Nov 22, 2001·Bioconjugate Chemistry·S FutakiY Sugiura
May 25, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·M Lee LucasRichard Heller
Aug 16, 2002·Pharmaceutical Research·Bernd H ZinselmeyerIjeoma F Uchegbu
Oct 9, 2003·Biological Research for Nursing·Jiang Liu, Joseph I Shapiro
Jun 19, 2004·Journal of Drug Targeting·Corine C VisserAlbertus G De Boer
Nov 27, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sergey A KaliberovDonald J Buchsbaum
Mar 1, 2005·Cytokine & Growth Factor Reviews·Simone MocellinDonato Nitti
Jan 27, 2007·Cellular and Molecular Life Sciences : CMLS·H Ryoung KimP Couvreur
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jan 2, 2009·Cancer Treatment Reviews·Devalingam MahalingamAfshin Samali
Apr 8, 2011·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Giovanni Tuccari, Gaetano Barresi
May 31, 2011·Frontiers in Bioscience (Scholar Edition)·Jessica A GibbonsJagat R Kanwar
Mar 1, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Minyan WeiChuanbin Wu
Apr 15, 2014·Disease-a-month : DM·Daniel M SamanMartin S Lipsky
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
May 3, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Li Ying LimChristine Dufès
Sep 13, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sukrut SomaniChristine Dufès

❮ Previous
Next ❯

Citations

Dec 4, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Janelle W SalamehMarxa L Figueiredo
Feb 26, 2020·Antimicrobial Agents and Chemotherapy·Kenya E FernandesDee A Carter
Aug 25, 2019·Acta Pharmacologica Sinica·Hui-Hai ZhongYong-Zhuo Huang
Dec 9, 2020·Nutrition and Cancer·Armando Olivas, Ramona Salcedo Price
Nov 20, 2020·International Journal of Biological Macromolecules·Mona M Agwa, Sally Sabra
Jun 26, 2020·Advanced Drug Delivery Reviews·Alexandra S Piotrowski-DaspitW Mark Saltzman
Jul 8, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Reza MohammadinejadAli Zarrabi
Jul 9, 2021·International Journal of Nanomedicine·Jamal AlmowaladChristine Dufès

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
confocal microscopy
flow cytometry
confocal
xenograft
electrophoresis

Software Mentioned

FACSDiva
Living Image
Minitab

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.